Dogwood Therapeutics Files 8-K on Financials

Ticker: DWTX · Form: 8-K · Filed: May 8, 2025 · CIK: 1818844

Dogwood Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyDogwood Therapeutics, INC. (DWTX)
Form Type8-K
Filed DateMay 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, company-update

Related Tickers: DWTX

TL;DR

Dogwood Therapeutics (DWTX) filed an 8-K on May 8, 2025, detailing financial results and operations.

AI Summary

Dogwood Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company, formerly known as Virios Therapeutics, Inc., is incorporated in Delaware and headquartered in Alpharetta, Georgia.

Why It Matters

This 8-K filing provides an update on Dogwood Therapeutics' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial information and does not contain significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Dogwood Therapeutics, Inc.?

The primary purpose of this 8-K filing is to report on Dogwood Therapeutics, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on May 8, 2025.

What was Dogwood Therapeutics, Inc. formerly known as?

Dogwood Therapeutics, Inc. was formerly known as Virios Therapeutics, Inc. and Virios Therapeutics, LLC.

Where is Dogwood Therapeutics, Inc. headquartered?

Dogwood Therapeutics, Inc. is headquartered at 44 Milton Avenue, Alpharetta, GA 30009.

What is the Standard Industrial Classification (SIC) code for Dogwood Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Dogwood Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Dogwood Therapeutics, Inc. (DWTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing